ReP USP - Resultado da busca

Trabalho de evento-resumo
Isolation, identification, in vitro and in vivo anti-plasmodial activity of guanidine alkaloids from Monanchora aff. arbuscula (2023)
Noronha, Anderson Lombardo; Borges, Natália Menezes Moreira; Mendes, Giovana Rossi ; Amorim, Marcelo Rodrigues de ; Guido, Rafael Victorio Carvalho ; Hajdu, Eduardo Carlos Meduna; Ferreira, Antônio Gilberto ; Berlinck, Roberto Gomes de Souza
Fonte: Anais eletrônicos. Nome do evento: Brazilian Conference on Natural Products - BNCP. Unidades: IFSC, IQSC
Assuntos: PLANEJAMENTO DE FÁRMACOS, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Anderson Lombardo et al. Isolation, identification, in vitro and in vivo anti-plasmodial activity of guanidine alkaloids from Monanchora aff. arbuscula. 2023, Anais.. Campinas: Galoá, 2023. Disponível em: https://proceedings.science/bcnp-series/bcnp-2023/papers/isolation-identification-in-vitro-and-in-vivo-anti-plasmodial-activity-of-guanid?lang=en#. Acesso em: 04 ago. 2024.
APA
Noronha, A. L., Borges, N. M. M., Mendes, G. R., Amorim, M. R. de, Guido, R. V. C., Hajdu, E. C. M., et al. (2023). Isolation, identification, in vitro and in vivo anti-plasmodial activity of guanidine alkaloids from Monanchora aff. arbuscula. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/bcnp-series/bcnp-2023/papers/isolation-identification-in-vitro-and-in-vivo-anti-plasmodial-activity-of-guanid?lang=en#
NLM
Noronha AL, Borges NMM, Mendes GR, Amorim MR de, Guido RVC, Hajdu ECM, Ferreira AG, Berlinck RG de S. Isolation, identification, in vitro and in vivo anti-plasmodial activity of guanidine alkaloids from Monanchora aff. arbuscula [Internet]. Anais eletrônicos. 2023 ;[citado 2024 ago. 04 ] Available from: https://proceedings.science/bcnp-series/bcnp-2023/papers/isolation-identification-in-vitro-and-in-vivo-anti-plasmodial-activity-of-guanid?lang=en#
Vancouver
Noronha AL, Borges NMM, Mendes GR, Amorim MR de, Guido RVC, Hajdu ECM, Ferreira AG, Berlinck RG de S. Isolation, identification, in vitro and in vivo anti-plasmodial activity of guanidine alkaloids from Monanchora aff. arbuscula [Internet]. Anais eletrônicos. 2023 ;[citado 2024 ago. 04 ] Available from: https://proceedings.science/bcnp-series/bcnp-2023/papers/isolation-identification-in-vitro-and-in-vivo-anti-plasmodial-activity-of-guanid?lang=en#
Artigo de periodico
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 (2022)
Vries, Laura E. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho
Fonte: Nature Communications. Unidade: IFSC
Assuntos: PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, ANTIPARASITÁRIOS, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VRIES, Laura E. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, v. 13, p. 2158-1-2158-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-29688-5. Acesso em: 04 ago. 2024.
APA
Vries, L. E., Aguiar, A. C. C., & Guido, R. V. C. (2022). Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, 13, 2158-1-2158-16. doi:10.1038/s41467-022-29688-5
NLM
Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1038/s41467-022-29688-5
Vancouver
Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1038/s41467-022-29688-5
Artigo de periodico
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome (2021)
Xie, Stanley C. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho
Fonte: Proceedings of the National Academy of Sciences of the United States of America - PNAS. Unidade: IFSC
Assuntos: PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, MALÁRIA, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIE, Stanley C. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences of the United States of America - PNAS, v. 118, n. 39, p. e2107213118-1-e2107213118-9, 2021Tradução . . Disponível em: https://doi.org/10.1073/pnas.2107213118. Acesso em: 04 ago. 2024.
APA
Xie, S. C., Aguiar, A. C. C., & Guido, R. V. C. (2021). Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 118( 39), e2107213118-1-e2107213118-9. doi:10.1073/pnas.2107213118
NLM
Xie SC, Aguiar ACC, Guido RVC. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2021 ; 118( 39): e2107213118-1-e2107213118-9.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1073/pnas.2107213118
Vancouver
Xie SC, Aguiar ACC, Guido RVC. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2021 ; 118( 39): e2107213118-1-e2107213118-9.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1073/pnas.2107213118
Artigo de periodico
Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors (2021)
Okaniwa, Masanori; Aguiar, Anna Caroline Campos; Guido, Rafael Victorio Carvalho
Fonte: ACS Infectious Diseases. Unidade: IFSC
Assuntos: PLASMODIUM, MALÁRIA, ANTIMALÁRICOS, ANTIPARASITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OKANIWA, Masanori e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, v. 7, n. 6, p. 1680-1689, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.1c00020. Acesso em: 04 ago. 2024.
APA
Okaniwa, M., Aguiar, A. C. C., & Guido, R. V. C. (2021). Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, 7( 6), 1680-1689. doi:10.1021/acsinfecdis.1c00020
NLM
Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020
Vancouver
Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Agência de fomento